Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma

Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma

BackgroundIn patients with cardiovascular (CV) comorbidities that necessitate antiplatelet therapy (APT), its optimal management during chemotherapy-induced thrombocytopenia remains elusive, as the risk of bleeding has to be balanced against the risk of CV events. The purpose of this study was to as...

Full description

Bibliographic Details
Main Authors: Nina Rosa Neuendorff, Boryana Boshikova, Lutz Frankenstein, Marietta Kirchner, Christian Rohde, Hartmut Goldschmidt, Norbert Frey, Carsten Müller-Tidow, Karin Jordan, Sandra Sauer, Maike Janssen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
autologous stem-cell transplantation
antiplatelet therapy
aspirin
bleeding
cardio-vascular events
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1168120/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1168120/full

Similar Items